miR-301a expression: Diagnostic and prognostic marker for prostate cancer.
CONCLUSIONS: Expression of miR-301a could be a valuable adjunct tool for stratifying patients with elevated prostate-specific antigen, as well as those diagnosed with CaP. Including the miR-301a as an additional variable in MSKCC post-prostatectomy nomogram improved its ability in facilitating clinical decision-making.
PMID: 30195463 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Kolluru V, Chandrasekaran B, Tyagi A, Dervishi A, Ankem M, Yan X, Maiying K, Alatassi H, Shaheen SP, Haddad A, Damodaran C, C Messer J, Edwards A Tags: Urol Oncol Source Type: research
More News: Adenocarcinoma | Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Pathology | Prostate Cancer | Science | Study | Urology & Nephrology